Spectrophotometric, chromatographic and bioanalysis of selected recently approved drugs from 2015–2020 to treat cardiovascular diseases: an analytical review
Heart Study has been operating for more than 40 years, and throughout that time it has found a number of risk variables that interact negatively to have an overall negative effect on cardiovascular disease (CVD) with an estimated 17.9 million deaths per year, CVD is the world's leading cause of...
Lưu vào:
| Tác giả chính: | |
|---|---|
| Đồng tác giả: | |
| Định dạng: | BB |
| Ngôn ngữ: | en_US |
| Thông tin xuất bản: |
2023
|
| Chủ đề: | |
| Truy cập trực tuyến: | http://tailieuso.tlu.edu.vn/handle/DHTL/12879 |
| Từ khóa: |
Thêm từ khóa bạn đọc
Không có từ khóa, Hãy là người đầu tiên gắn từ khóa cho biểu ghi này!
|
| id |
oai:localhost:DHTL-12879 |
|---|---|
| record_format |
dspace |
| spelling |
oai:localhost:DHTL-128792023-03-31T08:02:08Z Spectrophotometric, chromatographic and bioanalysis of selected recently approved drugs from 2015–2020 to treat cardiovascular diseases: an analytical review Gharge, Shankar Koli, Rahul Gudasi, Sachin I. Hiremath, Sushmita Cardiovascular disease Spectrophotometric Pharmaceutical dosage form Chromatographic U.S. FDA Heart Study has been operating for more than 40 years, and throughout that time it has found a number of risk variables that interact negatively to have an overall negative effect on cardiovascular disease (CVD) with an estimated 17.9 million deaths per year, CVD is the world's leading cause of death. https://link.springer.com/article/10.1186/s42269-023-01000-5 2023-03-31T08:02:08Z 2023-03-31T08:02:08Z 2023 BB 2522-8307 http://tailieuso.tlu.edu.vn/handle/DHTL/12879 en_US Bulletin of the National Research Centre, Volume 47 (2023), Article number: 24 |
| institution |
Trường Đại học Thủy Lợi |
| collection |
DSpace |
| language |
en_US |
| topic |
Cardiovascular disease Spectrophotometric Pharmaceutical dosage form Chromatographic U.S. FDA |
| spellingShingle |
Cardiovascular disease Spectrophotometric Pharmaceutical dosage form Chromatographic U.S. FDA Gharge, Shankar Spectrophotometric, chromatographic and bioanalysis of selected recently approved drugs from 2015–2020 to treat cardiovascular diseases: an analytical review |
| description |
Heart Study has been operating for more than 40 years, and throughout that time it has found a number of risk variables that interact negatively to have an overall negative effect on cardiovascular disease (CVD) with an estimated 17.9 million deaths per year, CVD is the world's leading cause of death. |
| author2 |
Koli, Rahul |
| author_facet |
Koli, Rahul Gharge, Shankar |
| format |
BB |
| author |
Gharge, Shankar |
| author_sort |
Gharge, Shankar |
| title |
Spectrophotometric, chromatographic and bioanalysis of selected recently approved drugs from 2015–2020 to treat cardiovascular diseases: an analytical review |
| title_short |
Spectrophotometric, chromatographic and bioanalysis of selected recently approved drugs from 2015–2020 to treat cardiovascular diseases: an analytical review |
| title_full |
Spectrophotometric, chromatographic and bioanalysis of selected recently approved drugs from 2015–2020 to treat cardiovascular diseases: an analytical review |
| title_fullStr |
Spectrophotometric, chromatographic and bioanalysis of selected recently approved drugs from 2015–2020 to treat cardiovascular diseases: an analytical review |
| title_full_unstemmed |
Spectrophotometric, chromatographic and bioanalysis of selected recently approved drugs from 2015–2020 to treat cardiovascular diseases: an analytical review |
| title_sort |
spectrophotometric, chromatographic and bioanalysis of selected recently approved drugs from 2015–2020 to treat cardiovascular diseases: an analytical review |
| publishDate |
2023 |
| url |
http://tailieuso.tlu.edu.vn/handle/DHTL/12879 |
| work_keys_str_mv |
AT ghargeshankar spectrophotometricchromatographicandbioanalysisofselectedrecentlyapproveddrugsfrom20152020totreatcardiovasculardiseasesananalyticalreview |
| _version_ |
1768589331653459968 |